[PDF] Top 20 COMPARATIVE STUDY ON EFFICACY AND SAFETY OF MYOINOSITOL VERSUS METFORMIN IN WOMEN WITH PCOS

... Recently, Myoinositol (MI) - a novel insulin sensitizer has been developed for treating PCOS with ...to metformin treatment because the former can affect insulin target tissues and cells and ... See full document

... the study of Zain et ...among PCOS females treated with metformin alone and metformin + CC ...i.e., metformin alone, CC alone, and combination ...that metformin can be used first ... See full document

... the efficacy of metformin and laparoscopic ovarian drilling to be used in anovulatory patients with polycystic ovarian syndrome (PCOS) for ovulation induction and preg- nancy ...with PCOS ... See full document

... A study on MI administration decreases the oxidative stress in erythrocytes of PCOD ...in women with this disorder and also increases the risk of cardiovascular events [12] ... See full document

... group, comparative study was conducted by the departments of pharmacology and orthopedics on patients undergoing lower limb surgery in a tertiary care hospital from January 2015 to July ...lactating ... See full document

... this study suggest that met- formin or OCPs can be at least efficacious and safe patient- convenient medications for the treatment of PCOS at this ...monitor PCOS women on these medications ... See full document

... unicentre study focusing on the evaluation of safety and efficacy of Metformin monotherpy with Metformin–Glimepiride combination therapy employed in the treatment of type-2 DM in the ... See full document

... years, metformin has gained acceptance as a safe, effective and rational option for reducing insulin resistance in pregnant women with type 2 diabetes, gestational diabetes (GDM) or polycystic ovarian ... See full document

... Chronic hyperglycemia is an important predictor of the development of diabetic complications like microvascular, macrovascular and acute metabolic complications. Chennai urban population study (CUPS) and the ... See full document

... Objective: PCOS is a common endocrine disorder in women of reproductive age associated with insulin ...resistance. Metformin and Myo-inositol being insulin sensitizers improve biochemical ...This ... See full document

... two PCOS groups, so data from the beginning of the study can be ...the PCOS with metformin group, after 6 months therapy, we observed a significant increase in PPTs in both measurement points ... See full document

... Ertugliflozin efficacy has also been evaluated as add-on or combination therapy with sitagliptin and ...the efficacy and safety of ertugliflozin, versus placebo, in patients with T2DM, ... See full document

... The small size of the particles, increases the total surface area of the silver exposed in solution, resulting in the highest possible effect per unit of silver. [18,19] In general, nanostructures can enter the body ... See full document

... Korean women with IDA during late stage preg- nancy showed that Hb increases were greater after FCM treatment compared with FS treatment, although the dif- ference was not statistically significant at week ...more ... See full document

... with PCOS had higher fasting insulin ...In PCOS women increased blood glucose (>110mg/dl) and fasting insulin (≥ 25µIUml) were noted in 8 women (16%) and 13 women (26%) ...21 ... See full document

... gitudinal studies that evaluated pancreatic cancer incidence rates in patients on EQW (or EBID or liraglutide) versus other antidiabetic agents have not been reported. In general terms, the American Diabetes ... See full document

... the study after obtaining written informed consent form and were selected based on the inclusion and exclusion ...the study. Men and women who were between 25-65 years of age were included in the ... See full document

... this study was undertaken ...better efficacy and minimal side effects and thereby safety of these drugs ...the efficacy of Propranolol ...the safety of Propranolol Vs Amitriptyline as ... See full document

... not be easy to accept new therapies when this means a further increase in costs, even if these drugs demonstrate to grant an improvement in patient’s quality of life. Hence, it follows the need to carry out cost analysis ... See full document

... present study was to assess the effects of metformin therapy for more than three months on BMI, WHR, fasting serum glucose (FSG) level, serum ferritin and insulin level and insulin resistance represented by ... See full document